Wockhardt Pharma gains as top line disappoints in Q4

NEW DELHI: Shares of Wockhardt Pharma ended with gains of 1.49 per cent after slipping 3 per cent in trade on Monday after the company’s top line saw a marginal downtick in the quarter ending March 31, 2016.

The net sales for the quarter under review stood at Rs 1,013.36 crore as compared to Rs 1,079.14 crore in the same quarter last fiscal.

It reported net profit of Rs 42.90 crore as against Rs 34.08 crore, signifying a rise of 26 per cent.

Reacting to the development, the scrip slumped 3.27 per cent to hit a low of Rs 906 on the BSE. The stock has tumbled 43 per cent in the year so far.